WAI CHUN BIOTEC released its annual performance, with a loss attributable to shareholders of HKD 14.623 million, a year-on-year decrease of 66.93%
According to the Zhitong Finance APP, WAI CHUN BIOTEC announced its annual performance for the year ending June 30, 2025, with revenue of HKD 377 million, an increase of 1.92% year-on-year; the loss attributable to the company's owners was HKD 14.623 million, a decrease of 66.93% year-on-year; the loss per share was HKD 0.0843. The announcement stated that the improvement in loss was mainly due to a significant reduction in impairment losses on non-financial assets incurred during the reporting year
According to the Zhitong Finance APP, WAI CHUN BIOTEC (00660) announced its annual performance for the year ending June 30, 2025. The group achieved revenue of HKD 377 million, an increase of 1.92% year-on-year; the loss attributable to the company's owners was HKD 14.623 million, a decrease of 66.93% year-on-year; the loss per share was HKD 0.0843.
The announcement stated that the improvement in loss was mainly due to a significant reduction in impairment losses on non-financial assets obtained during the reporting year
